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DObjective: The study objectivewas to quantify the effects of different annuloplasty rings onmitral leaflet septal-
lateral tenting areas during acute myocardial ischemia.
Methods:Radiopaque markers were implanted along the central septal-lateral meridian of the mitral valve in 30
sheep: 1 each to the septal and lateral aspects of the mitral annulus and 4 and 2 along the anterior and posterior
mitral leaflets, respectively. Ten true-sized Carpentier-Edwards Physio, Edwards IMR ETLogix, and GeoForm
annuloplasty rings (Edwards Lifesciences, Irvine, Calif) were inserted in a releasable fashion. Marker coordi-
nates were obtained using biplane videofluoroscopy with ring inserted at baseline (RING_BL) and after 90 sec-
onds of left circumflex artery occlusion (RING_ISCH). After ring release, another dataset was acquired before
(No_Ring_BL) and after left circumflex artery occlusion (No_Ring_ISCH). Anterior and posterior mitral leaflet
tenting areas were computed at mid-systole from sums of marker triangles with the midpoint between the
annular markers being the vertex for all triangles.
Results: Compared with No_Ring_BL, mitral regurgitation grades and all tenting areas significantly increased
with No_Ring_ISCH. Compared with No_Ring_ISCH, (1) all rings significantly prevented mitral regurgitation
and reduced all tenting areas; (2) Edwards IMR ETLogix and GeoForm rings reduced posterior mitral leaflet
area, but not anterior mitral leaflet tenting area, to a significantly greater extent than the Carpentier-Edwards
Physio ring; and (3) Edwards IMR ETLogix and GeoForm rings affected tenting areas similarly.
Conclusions: In response to acute left ventricular ischemia, disease-specific functional/ischemic mitral regur-
gitation rings (Edwards IMR ETLogix, GeoForm) more effectively reduced posterior mitral leaflet area, but not
anterior mitral leaflet tenting area, compared with true-sized physiologic rings (Carpentier-Edwards Physio).
Despite its radical 3-dimensional shape and greater amount of mitral annular septal-lateral downsizing, the
GeoForm ring did not reduce tenting areas more than the Edwards IMR ETLogix ring, suggesting that further
reduction in tenting areas in patients with FMR/IMR may not be effectively achieved on an annular level.
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The Journal of Thoracic and Caleads, via annular dilation and chordal tethering, to com-
plex 3-dimensional (3-D) alterations of the mitral valve ge-
ometry. While the central anterior leaflet belly displaces
toward the apex (leaflet tenting),2-7 the edges of the
anterior and posterior leaflets may displace apically,
prolapse, or both.8
Various parameters are available to describe and quan-
tify changes in leaflet geometry during FMR/IMR.3-7,9,10
One of the most common parameters to quantify the
degree of FMR/IMR includes the assessment of the
mitral leaflet tenting area, which describes the area
between mitral annulus and both leaflets in a central,
longitudinal, septal-lateral (S-L), mitral-annular cross-sec-
tion during systole. The amount of tenting area strongly
correlates with the severity of FMR/IMR6 and may be a pre-
dictive factor of recurrent mitral regurgitation (MR) in
patients with FMR/IMR who are undergoing mitral valve
repair.11
Although the results of surgical valve repair for FMR/
IMR have significantly improved, with rigid, undersized-
ring annuloplasty having become the current procedure of
choice,3 outcomes continue to be suboptimal with currentrdiovascular Surgery c Volume 141, Number 2 345
Abbreviations and Acronyms
AML ¼ anterior mitral leaflet
C-C ¼ commissure-commissure
ETL ¼ IMR ETLogix
FMR ¼ functional mitral regurgitation
GEO ¼ GeoForm
IMR ¼ ischemic mitral regurgitation
LCx ¼ left circumflex artery
LV ¼ left ventricular
MR ¼ mitral regurgitation
Physio ¼ PHYSIO
PML ¼ posterior mitral leaflet
S-L ¼ septal-lateral
3-D ¼ 3-dimensional
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DMR recurrence rates as high as approximately 15% (MR
grade  2þ) 3 to 5 years postoperatively.3,12
The primary reason for recurrent FMR/IMR is progres-
sive LV dilatation leading to increased leaflet tethering
and, ultimately, leaflet malcoaptation and recurrent regurgi-
tation.13 To account for the underlying pathophysiology,
disease-specific annuloplasty rings (Edwards GeoForm
[GEO], IMR ETLogix [ETL]; Edwards Lifesciences,
Irvine, Calif) have been designed that aim to treat these
typical subvalvular alterations on an annular level.
The key feature of these rings includes a disproportionate
reduction of the mitral annular S-L dimension. We recently
demonstrated that, compared with a Carpentier-Edwards
Physio (PHYSIO) ring, the approximate amount of S-L re-
duction includes 10% and 18% for the Edwards ETL ring
and 25% and 26% for the Edwards GEO ring in vitro14 and
in the normal beating ovine heart,15 respectively. To date, 2
clinical studies report the effects of the ETL on tenting
area5,16 and 1 study17 shows tenting volume after implanta-
tion of the GEO. Daimon and colleagues5 and Filsoufi and
colleagues16 report a reduction in tenting area of approxi-
mately 50% and 60%, respectively, after the implantation
of an ETL in 59 and 40 patients with IMR, respectively,
whereas Armen and colleagues17 demonstrate a reduction
in tenting volume of approximately 75% after implantation
of the GEO in a series of 7 patients with IMR. However, to
date no study has compared the effects of the different ring
types on mitral valve tenting area in a homogenous patient
population.
Our goal was therefore to quantify the effects of physio-
logic (Carpentier-Edwards PHYSIO) and IMR-specific
(Edwards GEO and ETL) annuloplasty rings on changes
in mitral valve tenting area during acute myocardial ische-
mia in an ovine model using 4-dimensional radiopaque
marker tracking and a releasable ring insertion technique.346 The Journal of Thoracic and Cardiovascular SurgMATERIALS AND METHODS
Surgical Preparation
Thirty-six adult, Dorsett-hybrid, male sheep (49 4 kg) were premedi-
cated with ketamine (25 mg/kg intramuscularly), anesthetized with sodium
thiopental (6.8 mg/kg intravenously), intubated, and mechanically venti-
lated with inhalational isoflurane (1.0%–2.5%). All animals received hu-
mane care in compliance with the Principles of Laboratory Animal Care
formulated by the National Society of Medical Research and the Guide
for Care and Use of Laboratory Animals prepared by the National Acad-
emy of Sciences and published by the National Institutes of Health
(DHEWNIHG publication 85–23, revised 1985). This study was approved
by the Stanford Medical Center Laboratory Research Animal Review
committee and conducted according to Stanford University policy.
Via a left thoracotomy, 13 radiopaque markers were implanted to sil-
houette the LVat the cross-section points of 4 equally spaced longitudinal
and 3 equatorial meridians as described previously.18 With the use of car-
diopulmonary bypass and cardioplegic arrest, 8 radiopaque markers were
implanted as follows: Two markers were sewn to the S-L aspect (numbers
22 and 18, Figure 1, A), and 2 markers were sewn to the anterior and
posterior mitral annular commissures, respectively. Four and two markers
were sutured along the S-L meridian of the anterior mitral leaflets (AMLs)
(A1–A4, Figure 1, A) and posterior mitral leaflets (PMLs) (P1 and P2,
Figure 1, A), respectively (single tantalum loops, 0.6 mm internal diameter,
1.1 mm outer diameter, 3.2 mg each). To allow each animal to serve as its
own control, a Carpentier-Edwards PHYSIO, an Edwards ETL, or an
Edwards GEO annuloplasty ring (Edwards Lifesciences) was implanted
in a releasable fashion as previously described.19
In brief, the mid parts of 8 double-armed polyester sutures were placed
evenly spaced through the annuloplasty ring before the operation using
a French eye needle, and the resulting loops were locked with polypropyl-
ene sutures (locking sutures). In addition, 2 drawstring sutures were
attached to the ring. During the operation, the ends of the 8 polyester
sutures were sewn equidistantly in a perpendicular direction from the ven-
tricular to the atrial side through the mitral annulus. The annuloplasty ring
was secured to the mitral annulus by tying these sutures. The locking
sutures and drawstrings were exteriorized, and the left atrium was closed.
Animals were randomly assigned to receive the Cosgrove-Edwards (Ed-
wards Lifesciences), St Jude Medical RSAR (St Paul, Minn), PHYSIO,
or GEO ring. Because this article focuses on the effects of IMR-specific an-
nuloplasty rings, data on the Cosgrove and RSAR rings are not reported.
After the implantation of these 4 ring types, the ETL was added. Conse-
quently, animals receiving this ring type were not randomized. All annulo-
plasty rings were true-sized by assessing the height and entire AML area.
Because all animals had similarly sized leaflets, all received size 28 rings.
The left circumflex artery (LCx) was then encircled with a vessel loop
immediately distal to the first obtuse marginal branch. The sheep, while
intubated and anesthetized, were then transferred with the chest open to
the experimental catheterization laboratory.
Data Acquisition
Some 6 of the 36 animals could not be used for data acquisition because
of complications related to the surgical procedure and induction of ische-
mia. Videofluoroscopic images (60 frames/sec) of all radiopaque markers
were acquired using biplane videofluoroscopy (Philips Medical Systems,
North America, Pleasanton, Calif). Figure 1,C shows the experimental pro-
tocol schematically. First, images were acquired with the ring inserted
under baseline (BL) conditions (PHYSIO:Ring_BL, ETL:Ring_BL,
GEO:Ring_BL). Acute LV ischemia was then induced by tightening the
LCx loop for 90 seconds, and another dataset under ischemic conditions
(ISCH) was obtained (PHYSIO:Ring_ISCH, ETL:Ring_ISCH, GEO:Rin-
g_ISCH). The locking sutures were then withdrawn, and the ring was lifted
away from the mitral annulus into the left atrium using the drawstrings.
After hemodynamic values returned to baseline, a third data acquisition
was performed and images were acquired under baseline conditionsery c February 2011
FIGURE 1. A,Marker array used to delineate the S-L aspects of the mitral
annulus (22 and 18), AML (A1-4), and PML (P1 and 2). B, Calculation of
AML and PML tenting areas. C, Experimental protocol timeline (see
‘‘Materials and Methods’’ for details). AML, Anterior mitral leaflet; BL,
baseline; ISCH, ischemia; PML, posterior mitral leaflet; TA, tenting area.
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GEO:No_Ring_BL). As described previously, these baseline data without
ring implanted are comparable to baseline data from studies in which no
ischemia was induced and no ring was implanted.19 After the acquisition
of baseline data with no ring implanted, 90 seconds of LCx ischemia
was induced (PHYSIO:No_Ring_ISCH, ETL:No_Ring_ISCH, GEO:-
No_Ring_ISCH). To determine whether 90 seconds of LCx occlusion
would be appropriate to assess differences among ring types, LV geometry
and papillary muscle displacement vectors during this ischemia period
were analyzed and found to be similar to historic studies from our labora-
tory in which longer periods of acute ischemia were induced.
Marker coordinates from 3 consecutive sinus rhythm beats from each of
the biplane views were then digitized andmerged to yield the time-resolved
3-D coordinates of each marker centroid in each frame using semiauto-
mated image processing and digitization software.20,21 Electrocardiogram
and analog LV pressure were recorded in real-time on the video images.
The amount of MR after each data acquisition run was independently
graded by an expert echocardiographer (D.H.L.) on the basis of color Dopp-
ler regurgitant jet extent and width22 and categorized as none (0), mild (þ1),
moderate (þ2), moderate-to-severe (þ3), or severe (þ4).
Data Analysis
For each beat, end diastole was defined as the videofluoroscopic frame
containing the peak of the R-wave on the electrocardiogram and end
systole as the frame preceding maximum peak rate fall of the LV pressure
(dP/dt). Distances between anterior and posterior leaflet edge (dAML/PML)
were computed throughout the cardiac cycle as distances between markersThe Journal of Thoracic and CaA1 and B1 (Figure 1, A). Closure Frame 1 was defined as the frame when
dAML/PML decreased to a stable minimum value with valve closure imme-
diately after end diastole. Closure Frame 2 was defined as the frame when
dAML/PML just began to increase with valve opening after isovolumic relax-
ation. Time of mid-systole was defined as ([Closure Frame 2 – Closure
Frame 1]/2)þClosure Frame 1.
Hemodynamics
Instantaneous LV volume was computed from the epicardial
LV markers using a space-filling multiple tetrahedral volume method20
(available at: http://circ.ahajournals.org/cgi/content/full/112/9_suppl/
I-423 - R17-M525485). Hemodynamic data were calculated from
marker-derived instantaneous LV volumes and analog LV pressures.23
Mitral Valve Tenting Area
Tenting area was computed at mid-systole from sums of marker trian-
gles with the mid point between the saddle horn (number 22, Figure 1,
A) and mid-lateral posterior annular marker (number 18, Figure 1, A) being
the vertex for all triangles (Figure 1, B). Markers 22, A1, A2, A3, A4, 18, P1,
and P2 were the base of the triangles for the total tenting area. To obtain
insight into ring effects on tenting area across AML and PML, total tenting
area was divided into AML and PML tenting area. Markers 22, A1, A2, A3,
and A4 were the base of the triangles for AML and 18; P1 and P2 were the
base of the triangles for the PML tenting areas (Figure 1, B). Percent
changes in tenting areas were calculated between No_Ring_ISCH
and Ring_ISCH as 100*(tenting area Ring_ISCH  tenting area
No_Ring_ISCH)/tenting area No_Ring_ISCH and between Ring_BL and
Ring_ISCH as 100*(tenting area Ring_ISCH  tenting area
No_Ring_BL)/tenting area No_Ring_BL.
Mitral Annular Dimensions
The S-L mitral annular dimension was calculated as the distance in 3-D
space between the saddle horn and mid-lateral posterior annular markers
(22 and 18, respectively), and the commissure-commissure (C-C) MA di-
mension was calculated as the distance between the anterior and posterior
commissural annular markers at mid-systole.
Statistical Analysis
Data are reported as mean  1 standard deviation unless otherwise
stated. Continuous data were compared within each group using the
2-tailed Student t test for paired observations with post hoc Bonferroni
correction. Ring types were contrasted by comparing absolute changes
in the individual states (No_Ring_BL vs No_Ring_ISCH, Ring_BL vs
Ring_ISCH, No_Ring_ISCH vs Ring_ISCH) among the 3 groups
(PHYSIO, ETL, GEO) using analysis of variance with post hoc Holm–
Sidak correction (Sigmastat 3.5, Systat Software, Inc, San Jose, CA).RESULTS
Hemodynamics
Table 1 summarizes the hemodynamic changes and mi-
tral annular dimensions measured under baseline conditions
(No_Ring_BL, Ring_BL) and during ischemia (No_Ring
_ISCH, Ring_ISCH), which were consistent with acute is-
chemia as reflected by increased LVend-diastolic pressure,
decreased maximum LV pressure, and dP/dt absolute
values. Heart rate did not change during ischemia. MR
grade was significantly greater during ischemia without
ring implantation (No_Ring_ISCH) in all groups compared
with baseline (No_Ring_BL); furthermore, all 3 rings effec-
tively prevented MR during acute LV ischemia.rdiovascular Surgery c Volume 141, Number 2 347
TABLE 1. Hemodynamic data and mitral annular dimensions
Physio (Edwards Lifesciences, Irvine, Calif) IMR ETLogix (Edwards Lifesciences)
No_Ring_BL No_Ring_ISCH Ring_BL Ring_ISCH No_Ring_BL
MR grade 0.6  0.2 1.1  0.4* 0.2  0.2 0.4  0.3 0.3  0.3
HR (min1) 93  13 90  11 92  12 90  14 82  7
LVEDV (mL) 124  24 133  34* 124  26 135  36z 126  21
dP/dtmax (mm Hg/sec) 1324  330 1005  231* 1365  332 1077  225z 1177  387
LVPmax (mm Hg) 94  9 71  7* 94  6 75  9z 94  4
S-L (cm) 2.73  0.27 2.95  0.31* 2.44  0.16 2.50  0.16z 2.80  0.21
C-C (cm) 3.92  0.23 4.00  0.28* 3.31  0.07 3.30  0.08z 3.87  0.26
MR, Mitral regurgitation; HR, heart rate; LVEDV, left ventricular end-diastolic volume; LVP, left ventricular pressure; S-L, septal-lateral; C-C, commissure-commissure; ISCH,
ischemia. All data are mean  1 standard deviation. *P<.05 vs No Ring BL. yP<.05 vs Ring BL. zP<.05 vs No Ring ISCH.
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Septal-lateral tenting areas. Without an annuloplasty
ring implanted, all tenting areas (total, AML, and PML
tenting area) increased significantly during ischemia
(No_Ring_BL vs No_Ring_ISCH, all P<.05; Figure 2).
Ring implantation significantly reduced all tenting areas
(total, AML, and PML tenting area) during LV ischemia
(No_Ring_ISCH vs Ring_ISCH, all P < .05; Figure 3,
A–C). Figure 4, A shows the relative changes in tenting
area in the individual states. During ischemia, the ETL
and GEO reduced total and PML tenting area (No_Ring_
ISCH vs Ring_ISCH: ETL vs PHYSIO, P<.05 and GEO
vs PHYSIO, P< .05; Figure 4, A), but not AML tenting
area compared with PHYSIO (No_Ring_ISCH vs Ring_
ISCH: ETL vs PHYSIO, not significant, and GEO vs
PHYSIO, not significant; Figure 4, A). The relative amount
of PML tenting area reduction during ischemia was approx-
imately 2 times greater with the ETL and GEO compared
with the PHYSIO (No_Ring_ISCH vs Ring_ISCH,
23.7%  10.1% and 22.1%  7.1% vs 11.0% 
7.5%, respectively, both P<.05; Figure 4, A).FIGURE 2. Total, AML, and PML, respectively, S-L tenting areas in an-
imals from all 3 groups with no ring implanted under baseline conditions
and during acute posterolateral LV ischemia. AML, Anterior mitral leaflet;
BL, baseline; ISCH, ischemia; PML, posterior mitral leaflet.
348 The Journal of Thoracic and Cardiovascular SurgFigure 3, D to F shows the changes in tenting areas with
the respective rings implanted (Ring BL vs Ring ISCH).
The induction of ischemia resulted in an increase of PML
tenting area in the PHYSIO group (Ring_BL vs Ring_-
ISCH, P<.05; Figure 3, D) and of total and AML tenting
area in the GEO group (Ring_BL vs Ring_ISCH, both
P<.05; Figure 3, F).Mitral Annular Dimensions
Table 1 shows the mitral annular dimensions for all
groups. With no ring implanted, mitral annular S-L and
C-C dimensions increased in all 3 groups during ischemia
(No_Ring_BL vs No_Ring_ISCH, all P< .005). Relative
to ischemia without ring, all rings significantly reduced
both mitral annular S-L and C-C diameter (No_Ring_ISCH
vs Ring_ISCH, all P<.005). Figure 4, B shows the relative
changes in mitral annular dimensions. The GEO provided
the greatest amount of mitral annular S-L reduction, fol-
lowed by the ETL and PHYSIO (GEO:30%  4% vs
ETL: 21%  4%, P< .05, and ETL: 21%  4% vs
PHYSIO:11%  8%, P<.05). In contrast, the PHYSIO
and ETL provided a greater amount of mitral annular C-C
reduction than the GEO (17%  4% and19%  3%
vs8%  5%, respectively, both P< .05). After any of
the 3 types of rings were implanted, no relevant changes
in mitral annular dimensions during ischemia were ob-
served (Ring_BL vs Ring_ISCH).DISCUSSION
The principal findings of this study were as follows: (1)
Acute posterolateral LV ischemia increased all tenting
areas, that is, total, AML, and PML tenting areas; (2) All
3 ring types reduced ischemia-induced increases in all 3
tenting areas; (3) ETL and GEO reduced total and PML,
but not AML tenting area, to a greater extent than the
PHYSIO; (4) GEO reduced the mitral annular S-L dimen-
sion to a greater extent than the ETL, but the effects of
the ETL and GEO on AML and PML tenting areas during
ischemia were similar.ery c February 2011
IMR ETLogix (Edwards Lifesciences) GeoForm (Edwards Lifesciences)
No_Ring_ISCH Ring_BL Ring_ISCH No_Ring_BL No_Ring_ISCH Ring_BL Ring_ISCH
1.2  1.2* 0.2  0.2 0.2  0.2 0.5  0.4 1.5  0.9* 0.2  0.2 0.2  0.3
82  6 80  10 82  7 91  10 92  10 92  11 93  10
130  23 126  21 131  22z 112  14 122  17* 110  13 121  16z
921  294* 1201  380 923  239z 1342  335 1012  242* 1407  448 1085  231z
72  9* 96  4 75  7z 95  10 74  7* 96  6 76  6z
3.00  0.20* 2.32  0.15 2.38  0.15y,z 2.67  0.21 2.91  0.21* 1.99  0.09 2.04  0.09y,z
3.96  0.24* 3.20  0.15 3.21  0.16z 3.74  0.27 3.83  0.30* 3.50  0.11 3.51  0.11z
TABLE 1. Continued
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DEffect of Acute Posterolateral Left Ventricular
Ischemia on Tenting Areas: No_Ring_BLVersus
No_Ring_ISCH
Without the presence of an annuloplasty ring, all
measured tenting areas (total, AML, and PML tenting
area) increased with acute localized posterolateral LV
wall ischemia. Watanabe and colleagues24 measured
AML and PML tenting heights in 12 patients with chronic
IMR using real time 3-D echocardiography and found that
maximum tenting occurred in the AML and never in the
PML. In contrast, we found that the absolute increases in
AML and PML tenting areas with no ring implanted
were identical (No_Ring_BL vs No_Ring_ISCH, AML:
þ0.09  0.07 cm2, PML:þ0.09  0.06 cm2). This discor-
dance in findings could be explained by several factors,
including the length of ischemia (acute vs chronic), the
site of LV wall ischemia (localized posterolateral vs
multi-segmental ischemia), the different species, or the dif-
ferences in imaging modalities used. Regardless of these
differences, our data indicate that PML tethering plays
an equally important role in the pathophysiology of IMR
under these acute experimental conditions. This hypothesis
is supported by Magne and colleagues,7 who found that the
degree of preoperative PML tethering is a predictive factor
for recurrent MR in patients with IMR undergoing ring
annuloplasty.
Effect of Annuloplasty Ring Implantation on Tenting
Areas During Acute Myocardial Ischemia:
No_Ring_ISCH Versus Ring_ISCH
To date, neither clinical nor experimental in vivo studies
exist comparing the effects of conventional annuloplasty
rings with disease-specific FMR/IMR rings on mitral valve
geometry or mitral annular dimensions during myocardial
ischemia. While all 3 ring types decreased all tenting areas
(and effectively prevented MR) in this in vivo experimental
ovine preparation, the amount of mitral annular S-L reduc-
tion was not directly proportional to the decrease in tenting
areas observed. The relative amount of mitral annular S-L
reduction during acute myocardial ischemia after ring
implantation (No_Ring_ISCH vs Ring_ISCH; Figure 4,
A) was smallest for the PHYSIO (15%  4%), greater
for the ETL (21%  4%), and largest for the GEOThe Journal of Thoracic and Ca(30%  4%). As expected from these values, the PHYSIO
decreased tenting area to the smallest extent (No_Ring_ISCH
vs Ring_ISCH; Figure 4, A). However, to our surprise, the
ETLandGEOprovided a similar amount of reduction in tent-
ing areas (Figure 4, A). Hypothetically, the GEO’s more rad-
ical mitral annular S-L downsizing could induce leaflet
displacements that may prevent further reduction of tenting
areas on an annular level. It is of note that the reductions in
tenting area observed in our study were considerably smaller
than those reported in clinical studies, in which the approxi-
mate decrease in tenting area included 50% to 60% after
ETL ring implantation5,16 and 75% in tenting volume after
GEO implantation.10 These observed discrepancies are
most probably due to a greater tethering (and, thus, greater
tenting areas) of the mitral valve before ring implantation
in patients with chronic IMR.
Effect of Ischemia on Tenting Areas With
Annuloplasty Rings Inserted: Ring_BLVersus
Ring_ISCH
Another interesting observation was that tenting areas
may be affected by regional ischemia despite the presence
of an annuloplasty ring (increases in total and AML tenting
area with the GEO and in PML tenting area with the
PHYSIO; Figure 3, D and F). These increaes in tenting
area are most probably due to ischemia-induced alterations
of the subvalvular apparatus and may therefore provide fur-
ther evidence for the theory that annuloplasty ring implan-
tation alone is not effective in preventing the recurrence of
mitral regurgitation due to ongoing LV dilation.
Clinical Inferences
As mentioned above, the GEO provided the greatest
amount of mitral annular septal-lateral downsizing, but
did not reduce tenting areas to a greater extent than ETL.
We therefore speculated that such radical mitral annular
S-L downsizing could induce leaflet displacements that
may prevent further reduction of tenting areas on an annular
level. It is conjectured that the addition of a subvalvular ad-
junctive procedure, for example, as proposed by Kron and
colleagues25 or Langer and colleagues,26 may provide addi-
tional benefit in terms of tenting area reduction. Further-
more, compared with the PHYSIO ring, the ETL andrdiovascular Surgery c Volume 141, Number 2 349
FIGURE 3. Total, AML, and PML, respectively, S-L tenting areas in animals from all 3 groups during acute posterolateral LV ischemia with and without
annuloplasty ring (A–C) and with annuloplasty rings implanted under baseline conditions and during ischemia (D–F). AML, Anterior mitral leaflet; PML,
posterior mitral leaflet; GEO, GeoForm; PHYSIO, Physio; ETL, IMR ETLogix.
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DGEO rings were more effective in reducing PML, but not
AML, tenting area. These findings indicate that the main
effect of annuloplasty rings is to pull the PML toward the
AML, which, at least in this acute model, suggests that
IMR annuloplasty rings should be designed to target the
posterior muscular mitral annular sector instead of the
fibrous anterior portion of the mitral annulus.350 The Journal of Thoracic and Cardiovascular SurgLimitations
Caution is certainly necessary in extrapolating these
acute experimental findings to patients. First, differences
between ovine and human mitral valve anatomy exist.
Walmsley27 reported that the central zone of the AML is
more rigid in sheep hearts than in human hearts. Such rigid-
ity might attenuate alterations in tenting area comparedery c February 2011
FIGURE 4. Relative changes in tenting area (A) and mitral annular diam-
eters (B) among the respective experimental conditions (see ‘‘Materials
and Methods’’ for details). AML, Anterior mitral leaflet; PML, posterior
mitral leaflet; C-C, commissure-commissure; S-L, septal-lateral; BL, base-
line; ISCH, ischemia.
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because ovine leaflets are nonetheless flexible. Further-
more, from our own experience, the position of the papillary
muscles relative to the leaflets may be slightly different in
sheep versus humans, and thus could impair the extrapola-
tion of our findings to patients. Second, the pathologic per-
turbations of this acute ischemic experimental preparation
undoubtedly differ from those in patients with chronic
FMR/IMR, even though previous studies from our labora-
tory have shown that papillary muscle displacement differs
only slightly between acute and chronic ovine ischemic
models. For example, in an ovine model of acute IMR,
Lai and colleagues28 found anteroapical and posterobasal
displacement of the anterior and posterior papillary muscleThe Journal of Thoracic and Catips, respectively, whereas Tibayan and colleagues29 in-
duced chronic IMR in sheep and noted posterolateral and
posterolateral plus basal displacement of the anterior and
posterior papillary muscle tips, respectively. These differ-
ences in 3-D papillary muscle behavior between acute and
chronic ischemia presumably affect 3-D leaflet geometry.
Ryan and colleagues9 found that the tenting sites with ische-
mic MR were most prominent between the 2 commissures
during acute IMR, but more pronounced toward the anterior
commissure during chronic IMR. Future studies in a chronic
experimental setting or in patients with chronic IMR that
focus on the effects of rings are needed. A third limitation
is that downsized ring annuloplasty is the procedure of
choice when using PHYSIO rings in patients with IMR/
FMR,3,30,31 but in our study, disease-specific IMR ETL
and GEO rings were compared with true-sized PHYSIO
rings. The benefit of disease-specific ring designs compared
with a downsized PHYSIO ring can therefore not be as-
sessed, and no recommendation can be made with respect
to the use of a PHYSIO ring for the treatment of IMR.
Fourth, our experimental approach tracks distinct anatomic
landmarks in all 3 dimensions and, thus, includes displace-
ments of the respective structures in any direction in 3-D
space. Consequently, our results may differ from tenting
area measurements obtained from clinical imaging tech-
niques where only one 2-dimensional longitudinal cross-
sectional view is obtained. Last, the quantification of tent-
ing areas and the separation into AML and PML tenting
area after valve repair using current clinical imaging modal-
ities may be difficult because of artifacts resulting from ring
implantation.CONCLUSIONS
Disease-specific FMR/IMR rings (ETL, GEO) reduce
total tenting area to a greater extent in response to acute
LV ischemia than true-sized PHYSIO rings, predominantly
via reducing PML tenting area. However, despite its radical
3-D shape and greater amount of mitral annular S-L down-
sizing, the GEO ring did not reduce tenting areas more than
the ETL ring, suggesting that radical S-L downsizing could
induce leaflet displacements that may prevent a further re-
duction of tenting areas on an annular level. Clinical studies
are needed to determine whether these findings translate to
patients.
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Dr Y. Joseph Woo (Philadelphia, Pa). I congratulate you on
some fantastic large animal work and a creative model. My ques-
tion relates to your choice of a single S-L line and 3 points along
that line for evaluating the unique plane for your tenting area. That
is valid in a planar ring, but in a radically nonplanar surface, the
point you have chosen is sort of a high point in the GeoForm
ring and therefore does not represent the geometry of the tenting
area to the left and right of the posterior midpoint. Would it be
markedly different if you integrated across, say, 3 vertical lines,
maybe one through the middle and then one perhaps 1 cm to the
right and 1 cm to the left?
Dr Bothe. You are absolutely right that annuloplasty rings, es-
pecially the IMR ETLogix, which is asymmetrically designed,
could affect tenting areas in different regions differently. However,
our analyses depend on our marker placement. Because we did not
place markers on the posterior leaflet in the meridians you men-
tioned, we cannot determine such changes at this point. It would
include an interesting future analysis.
Dr Eugene Grossi (New York, NY). A wonderful experiment.
Just a question on your experimental design. Why did you choose
a true-size Physio ring? All clinical expertise and use of this ring
is in downsizing, and if that is the case, you could think that there
are no differences if you just use a ring that gives you a fair
amount of S-L shortening to make the subject more ischemia-re-
sistant.
Dr Bothe. It would be desirable to have an additional animal
group that received downsized Physio rings. In this experiment
we chose to use rings that had similar nominal sizes because that
allowed us to get an impression about the magnitude of changes
of disease-specific rings compared with the Physio ring. Forery c February 2011
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of a downsized Physio and would be similar to an IMR ETLogix or
a GeoForm.
DrRakesh Suri (Rochester, Minn). Can you share any informa-
tion regarding the echocardiographic findings? Did the differences
in mitral tenting correspond to persistence of MR? What is your
hypothesis regarding the effectiveness of ring-induced annular re-
shaping in preventing recurrence of MR in the setting of chronic
ischemia where we know there is progressive and ongoing remod-
eling of the ventricle?
Dr Bothe. To answer your first question regarding the MR
grades, all MR grades increased without a ring implanted, meaning
from baseline to ischemia with no ring inserted, all animals devel-
oped MR and the MR grades were significantly higher. All rings
(Physio, IMR ETLogix, and GeoForm) eliminated the occurrence
of acute MR style.
Dr Suri. All rings?
Dr Bothe. Yes, all rings. As for the chronic setting, I agree with
you that chronic IMR may affect leaflet geometry differently; for
example, this has been shown by Gorman and colleagues in
a chronic experimental setting [Gorman JH III, Gorman RC, Jack-
son BM, Enomoto Y, St John-Sutton MG, Edmunds LH Jr. Annu-
loplasty ring selection for chronic ischemic mitral regurgitation:
lessons from the ovine model. Ann Thorac Surg. 2003;76:1556-
63]. To get an impression about the effects of acute ischemia on
papillary muscle geometry in our acute experimental setup, we
looked at ventricular changes and papillary muscle displacement.
The papillarymuscles displaced by approximately 7mm in the pos-
terolateral direction, which is close to a chronic scenario, but not
identical. So although wewould expect changes in the chronic sce-
nario to be similar, it could well be that they are slightly different.
Dr John Ikonomidis (Charleston, SC). In the setting of this
acute regional ischemic model, what are the physical determinantsThe Journal of Thoracic and Caof mitral leaflet tenting? Why does it occur? What are the things at
play?
Dr Bothe. Pretty much all components of the mitral valve com-
plex can be involved in the pathophysiology of IMR. However, the
major physical determinants in our acute model included mitral
annular dilatation, LV dilatation, and a displacement of the
papillary muscles, mainly the posteromedial papillary muscle.
Dr Ikonomidis. So what you are measuring is actually area
under a flat plane on the annulus, and we need to quantify mitral
leaflet tenting.
Dr Bothe. Yes.
Dr Ikonomidis. How are you modifying that area with these
rings? Are you just bringing the leaflets closer together?
Dr Bothe. That is a good question, because the tenting area is
basically a function of mitral annular dimension and the leaflet sur-
face. We know that the GeoForm decreases the mitral annular S-L
dimension to a greater extent than the IMRETLogix. However, our
data suggest that radical S-L downsizing could induce leaflet
displacements and increased leaflet tethering that, in turn, may
prevent a further reduction in tenting area.
Dr Ikonomidis. So does reduction in the S-L dimension
directly result in modification of papillary muscle displacement?
Dr Bothe. It could enhance leaflet tethering, but it does not nec-
essarily affect the position of the papillary muscle. We will look at
rings effects on the papillary muscles in a future analysis.
Dr Ikonomidis. My point being that it sounds as though with
these rings you are not modifying the direct primary cause of..
Dr Bothe. That is correct.
Dr Ikonomidis. And that raises the question of durability of
these repairs despite functional improvement acutely.
Dr Bothe. Yes, I think our data even provide certain evidence
that it may not be sufficient to treat IMR solely on an annular
level.rdiovascular Surgery c Volume 141, Number 2 353
